{"id":"W2793234123","doi":"10.1002/mdc3.12613","title":"Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose‐Escalation Multicenter Study","year":2018,"lang":"en","type":"article","venue":"Movement Disorders Clinical Practice","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Dystonia Coalition; Allergan; St. Jude Medical; National Institutes of Health; Merz Pharmaceuticals; National Institute of Neurological Disorders and Stroke; University of Cambridge; Glenmark Pharmaceuticals; Ipsen; Jazz Pharmaceuticals; Prothena; Neurocrine Biosciences; Revance; Psyadon Pharmaceuticals; Bristol-Myers Squibb; American Board of Psychiatry and Neurology; Acorda Therapeutics; H. Lundbeck A/S; Sunovion; American Academy of Neurology; F. Hoffmann-La Roche; Civitas Therapeutics; Parkinson's Foundation; Adamas Pharmaceuticals; ACADIA Pharmaceuticals; CHDI Foundation; Medtronic; Sanofi; Pfizer; Parkinson's Disease Foundation; US WorldMeds; Teva Pharmaceutical Industries; Kyowa Kirin Pharmaceutical Development; U.S. Department of Veterans Affairs","keywords":"Cervical dystonia; Medicine; Dystonia; Multicenter study; Anesthesia; Internal medicine; Psychiatry","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003693178,0.001751563,0.002085143,0.0005937356,0.0003964565,0.001060781,0.001093129,0.001403513,0.004502272],"category_scores_gemma":[0.001490018,0.0006333946,0.001575427,0.0005310898,0.0007543866,0.0008577662,0.0004135703,0.002622788,0.0009206434],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001482614,"about_ca_system_score_gemma":0.002286099,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001503507,"about_ca_topic_score_gemma":0.003203321,"domain_scores_codex":[0.9990163,0.0004122889,0.00005181429,0.0001587447,0.0001644848,0.0001963561],"domain_scores_gemma":[0.9992939,0.0001042565,0.0002033658,0.0000851737,0.0001021078,0.0002111659],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5662606,0.1568483,0.00804485,0.002958614,0.00427561,0.0004415872,0.0009123698,0.002976916,0.08923746,0.000627971,0.008276934,0.1591388],"study_design_scores_gemma":[0.5763208,0.4018133,0.01209592,0.0001254166,0.0008053155,0.0003184267,0.00008457521,0.001294493,0.003251613,0.0002357162,0.003602877,0.00005159291],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9833865,0.002955188,0.00136294,0.0005996138,0.000130033,0.00852447,0.001440085,0.0001464786,0.001454728],"genre_scores_gemma":[0.9645178,0.005009853,0.005710721,0.001983724,0.0002453321,0.01480381,0.003194979,0.00007438579,0.004459402],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004502272,"threshold_uncertainty_score":0.01953161,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0432660669349459,"score_gpt":0.4172289391426123,"score_spread":0.3739628722076664,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}